Radstake TR - Search Results

1

The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.

Rueda B, Broen J, Torres O, Simeon C, Ortego-Centeno N, Schrijvenaars MM, Vonk MC, Fonollosa V, van den Hoogen FH, Coenen MJ, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Martin J, Radstake TR. Rueda B, et al. Among authors: radstake tr. Ann Rheum Dis. 2009 Feb;68(2):253-6. doi: 10.1136/ard.2008.096719. Epub 2008 Aug 19. Ann Rheum Dis. 2009. PMID: 18713787

2

The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.

Radstake TR, Franke B, Wenink MH, Nabbe KC, Coenen MJ, Welsing P, Bonvini E, Koenig S, van den Berg WB, Barrera P, van Riel PL. Radstake TR, et al. Arthritis Rheum. 2006 Dec;54(12):3828-37. doi: 10.1002/art.22275. Arthritis Rheum. 2006. PMID: 17133580 Free article.

3

Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.

van Lieshout AW, Fransen J, Flendrie M, Eijsbouts AM, van den Hoogen FH, van Riel PL, Radstake TR. van Lieshout AW, et al. Among authors: radstake tr. Ann Rheum Dis. 2007 Oct;66(10):1334-8. doi: 10.1136/ard.2006.066084. Epub 2007 Mar 9. Ann Rheum Dis. 2007. PMID: 17350968 Free PMC article.

4

Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.

Radstake TR, Fransen J, Toonen EJ, Coenen MJ, Eijsbouts AE, Donn R, van den Hoogen FH, van Riel PL. Radstake TR, et al. Ann Rheum Dis. 2007 Nov;66(11):1525-30. doi: 10.1136/ard.2006.064394. Epub 2007 Apr 24. Ann Rheum Dis. 2007. PMID: 17456524 Free PMC article.

5

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P. Popa C, et al. Among authors: radstake tr. Ann Rheum Dis. 2007 Nov;66(11):1503-7. doi: 10.1136/ard.2006.066191. Epub 2007 May 1. Ann Rheum Dis. 2007. PMID: 17472994 Free PMC article. Clinical Trial.

6

Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.

Alizadeh BZ, Valdigem G, Coenen MJ, Zhernakova A, Franke B, Monsuur A, van Riel PL, Barrera P, Radstake TR, Roep BO, Wijmenga C, Koeleman BP. Alizadeh BZ, et al. Among authors: radstake tr. Hum Mol Genet. 2007 Nov 1;16(21):2552-9. doi: 10.1093/hmg/ddm194. Epub 2007 Jul 25. Hum Mol Genet. 2007. PMID: 17652100

7

Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

Zhernakova A, Alizadeh BZ, Bevova M, van Leeuwen MA, Coenen MJ, Franke B, Franke L, Posthumus MD, van Heel DA, van der Steege G, Radstake TR, Barrera P, Roep BO, Koeleman BP, Wijmenga C. Zhernakova A, et al. Among authors: radstake tr. Am J Hum Genet. 2007 Dec;81(6):1284-8. doi: 10.1086/522037. Epub 2007 Oct 24. Am J Hum Genet. 2007. PMID: 17999365 Free PMC article.

8

Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.

Radstake TR, Fransen J, van Riel PL, Toonen E, Coenen M, Donn R. Radstake TR, et al. Ann Rheum Dis. 2008 Jan;67(1):134-5. doi: 10.1136/ard.2007.079111. Ann Rheum Dis. 2008. PMID: 18077543 No abstract available.

9

Gene expression profiling in rheumatoid arthritis: current concepts and future directions.

Toonen EJ, Barrera P, Radstake TR, van Riel PL, Scheffer H, Franke B, Coenen MJ. Toonen EJ, et al. Among authors: radstake tr. Ann Rheum Dis. 2008 Dec;67(12):1663-9. doi: 10.1136/ard.2007.076588. Epub 2008 Feb 4. Ann Rheum Dis. 2008. PMID: 18250114 Review.

10

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen EJ, Coenen MJ, Kievit W, Fransen J, Eijsbouts AM, Scheffer H, Radstake TR, Creemers MC, de Rooij DJ, van Riel PL, Franke B, Barrera P. Toonen EJ, et al. Among authors: radstake tr. Ann Rheum Dis. 2008 Aug;67(8):1174-7. doi: 10.1136/ard.2008.088138. Epub 2008 Apr 2. Ann Rheum Dis. 2008. PMID: 18385279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters